Cite
Goto Y, Tanai C, Yoh K, et al. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study. ESMO Open. 2017;2(4):e000214doi: 10.1136/esmoopen-2017-000214.
Goto, Y., Tanai, C., Yoh, K., Hosomi, Y., Sakai, H., Kato, T., Kaburagi, T., Nishio, M., Kim, Y. H., Inoue, A., Hasegawa, Y., Isobe, H., Tomizawa, Y., Mori, Y., Minato, K., Yamada, K., Ohashi, Y., & Kunitoh, H. (2017). Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study. ESMO open, 2(4), e000214. https://doi.org/10.1136/esmoopen-2017-000214
Goto, Yasushi, et al. "Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study." ESMO open vol. 2,4 (2017): e000214. doi: https://doi.org/10.1136/esmoopen-2017-000214
Goto Y, Tanai C, Yoh K, Hosomi Y, Sakai H, Kato T, Kaburagi T, Nishio M, Kim YH, Inoue A, Hasegawa Y, Isobe H, Tomizawa Y, Mori Y, Minato K, Yamada K, Ohashi Y, Kunitoh H. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study. ESMO Open. 2017 Sep 14;2(4):e000214. doi: 10.1136/esmoopen-2017-000214. eCollection 2017. PMID: 29018574; PMCID: PMC5604715.
Copy
Download .nbib